Samuraciclib hydrochloride hydrate
Samuraciclib (CT7001) hydrochloride hydrate is an orally bioavailable, ATP-competitive, and selective CDK7 inhibitor (IC50 = 41 nM) . It demonstrates potent anti-proliferative activity in breast cancer cell lines (GI50 0.2-0.3 μM) and has shown efficacy in vivo, supporting its investigation in oncology research, particularly for hormone receptor-positive breast cancer.
Product Specifications
Field of Research
Cell Biology
Molecular Formula
C22H35ClN6O3
Molecular Weight
521.7
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LV776239 1.0 µg DNA
RPL10P16 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro)
Sign In for Pricing
View Details 
VAng-Lsx7184-1mgEcoli 1 mg (E. coli)
Recombinant Chlamydophila Trachomatis rpsD Protein (aa 1-209) (strain D/UW-3/Cx)
Sign In for Pricing
View Details 
